You are here: Home » PTI Stories » National » News
Business Standard

AstraZeneca joins hands with Nasscom to set up accelerator programme in healthcare

Press Trust of India  |  New Delhi 

Global biopharmaceutical and IT industry body Thursday joined hands to set up an accelerator programme to support Indian in

At the India-Unnati 2.0 day event here, and its partners, Sweden, Nasscom, Atal Innovation Mission-Niti Aayog and AGNIi also announced the finalists of the Unnati Innovation Challenge.

The selected winners among the finalists will receive mentorship support from AstraZeneca, which will contribute its unique with the aim of helping the finalists bring their solutions to market.

has launched a strategic partnership with the IoT Centre of Excellence to set up an accelerator programme to support Indian develop new innovative solutions to (NCDs) care in

Under this collaboration, AstraZeneca and will incubate in bringing innovative and that can help in the management of NCDs.

Leif Johansson told PTI: "Best healthcare that can be provided and developed comes from cooperation across borders between industry, government and academia in a such way that we, with the help of technology, can provide a higher-quality service at a lower cost."

AstraZeneca is committed to strengthening innovation in healthcare in India, he added.

In a statement, Johansson said: "We are pleased to collaborate with the government, start-up eco-system and industry partners to achieve the shared vision of making meaningful interventions in improving the lives of patients impacted by in "

Highlighting the Unnati initiative, Sweden's Trade to said: "Unnati is a model for co-innovation allowing industry, start-ups and the to jointly develop solutions addressing global social needs."

This challenge calls for collaboration to implement early and remote screening as well as efficient AI-based patient management, he added.

When asked about the importance of India as a market for AstraZeneca, Johansson said: "India is important to us as a market... My vision would be that India becomes an important, large part of the AstraZeneca group not only for India but also in India for global market.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, February 21 2019. 15:35 IST